BioSpace News Archive

Business

NuVasive Announces Second Quarter 2023 Financial Results

NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the quarter ended June 30, 2023.

August 2, 2023
·
25 min read
Business

REGENXBIO Reports Second Quarter 2023 Financial Results and Recent Operational Highlights

REGENXBIO Inc. (Nasdaq: RGNX) today announced financial results for the second quarter ended June 30, 2023, and recent operational highlights.

August 2, 2023
·
18 min read
Business

STAAR Surgical Reports Second Quarter 2023 Results

STAAR Surgical Company, a leading developer, manufacturer and marketer of implantable lenses for the eye, reported financial results for the second quarter ended June 30, 2023.

August 2, 2023
·
23 min read
Biotech Bay

Adicet Bio to Participate in a Fireside Chat at the Canaccord Genuity 43rd Annual Growth Conference

Adicet Bio, Inc. (Nasdaq: ACET) today announced that Chen Schor, President and Chief Executive Officer, will participate in a fireside chat at the Canaccord Genuity 43rd Annual Growth Conference being held from August 7-10, 2023 in Boston.

August 2, 2023
·
1 min read
Business

Cerus Corporation Announces Second Quarter 2023 Financial Results

Cerus Corporation (Nasdaq: CERS) today announced financial results for the second quarter ended June 30, 2023.

August 2, 2023
·
20 min read
Business

Molecular Templates Announces Executive Leadership Changes - August 02, 2023

Molecular Templates, Inc. announced executive management changes to implement its next phase of development.

August 2, 2023
·
6 min read
Lone Star Bio

Natera to Participate in Canaccord Genuity 43rd Annual Growth Conference

Natera, Inc. announced that members of its leadership team will present at the Canaccord Genuity 43rd Annual Growth Conference on Wednesday, Aug. 9 at 4:30 pm ET | 1:30 pm PT in Boston, MA.

August 2, 2023
·
1 min read
Business

Evolent Announces Second Quarter 2023 Results

Evolent Health, Inc. announced financial results for the quarter ended June 30, 2023.

August 2, 2023
·
31 min read
Business

Acadia Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operating Overview

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced its financial results for the second quarter ended June 30, 2023.

August 2, 2023
·
11 min read
Business

Evolus Reports Second Quarter 2023 Results and Provides Business Update

Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported financial results for the second quarter ended June 30, 2023 and provided a business update.

August 2, 2023
·
18 min read